Re: Adjuvant Radiotherapy versus Early Salvage Radiotherapy plus Short-Term Androgen Deprivation Therapy in Men with Localised Prostate Cancer after Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 Trial

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 205卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1225 / 1225
页数：1
相关论文
共 50 条
  • [21] The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.
    Guerif, Stephane Gilles
    Latorzeff, Igor
    Roca, Lise
    Allouache, Djelila
    Supiot, Stephane
    Lagneau, Edouard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [22] Re: Androgen-Deprivation Therapy Alone or with Docetaxel in Non-Castrate Metastatic Prostate Cancer (GETUG-AFU 15): A Randomised, Open-Label, Phase 3 Trial Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2013, 190 (06): : 2094 - 2094
  • [23] High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial
    Zapatero, Almudena
    Guerrero, Araceli
    Maldonado, Xavier
    Alvarez, Ana
    Gonzalez San Segundo, Carmen
    Cabeza Rodriguez, Maria Angeles
    Macias, Victor
    Pedro Olive, Agusti
    Casas, Francesc
    Boladeras, Ana
    Martin de Vidales, Carmen
    Vazquez de la Torre, Maria Luisa
    Villa, Salvador
    Perez de la Haza, Aitor
    Calvo, Felipe A.
    LANCET ONCOLOGY, 2015, 16 (03): : 320 - 327
  • [24] Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
    Kneebone, Andrew
    Fraser-Browne, Carol
    Duchesne, Gillian M.
    Fisher, Richard
    Frydenberg, Mark
    Herschtal, Alan
    Williams, Scott G.
    Brown, Chris
    Delprado, Warick
    Haworth, Annette
    Joseph, David J.
    Martin, Jarad M.
    Matthews, John H. L.
    Millar, Jeremy L.
    Sidhom, Mark
    Spry, Nigel
    Tang, Colin, I
    Turner, Sandra
    Wiltshire, Kirsty L.
    Woo, Henry H.
    Davis, Ian D.
    Lim, Tee S.
    Pearse, Maria
    LANCET ONCOLOGY, 2020, 21 (10): : 1331 - 1340
  • [25] Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial
    Berghen, Charlien
    Joniau, Steven
    Laenen, Annouschka
    Devos, Gaetan
    Rans, Kato
    Goffin, Karolien
    Haustermans, Karin
    De Meerleer, Gert
    FUTURE ONCOLOGY, 2020, 16 (27) : 2035 - 2044
  • [26] Re: High-Dose Radiotherapy with Short-Term or Long-Term Androgen Deprivation in Localised Prostate Cancer (DART01/05 GICOR): A Randomised, Controlled, Phase 3 Trial Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 194 (04): : 989 - 990
  • [27] Place of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy: A phase III trial
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Souhami, Luis
    Lemaire, Celine
    Brassard, Marc-Andre
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Thu-Van Nguyen-Huynh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [28] A phase III trial of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy.
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Souhami, Luis
    Lemaire, Celine
    Brassard, Marc-Andra
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Thu-Van Nguyen-Huynh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trial
    Marino, P.
    Sfumato, P.
    Joly, F.
    Fizazi, K.
    Oudard, S.
    Culine, S.
    Habibian, M.
    Boher, J-M.
    Gravis, G.
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 27 - 33
  • [30] Androgen deprivation therapy (ADT) plus docetaxel (D) versus ADT alone for hormone-naive metastatic prostate cancer (PCa): Long-term analysis of the GETUG-AFU 15 phase III trial.
    Gravis, Gwenaelle
    Boher, Jean-Marie
    Joly, Florence
    Oudard, Stephane
    Albiges, Laurence
    Priou, Franck
    Latorzeff, Igor
    Delva, Remy
    Krakowski, Ivan
    Laguerre, Brigitte
    Rolland, Frederic
    Theodore, Christine
    Deplanque, Gael
    Ferrero, Jean-Marc
    Pouessel, Damien
    Mourey, Loic
    Beuzeboc, Philippe
    Habibian, Muriel
    Soulie, Michel
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345